Check-Cap Ltd. (CHEK): Price and Financial Metrics


Check-Cap Ltd. (CHEK): $1.63

-0.01 (-0.61%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CHEK Stock Price Chart Interactive Chart >

Price chart for CHEK

CHEK Price/Volume Stats

Current price $1.63 52-week high $4.49
Prev. close $1.64 52-week low $0.24
Day low $1.61 Volume 1,061,700
Day high $1.65 Avg. volume 14,814,671
50-day MA $1.54 Dividend yield N/A
200-day MA $1.10 Market Cap 75.37M

Check-Cap Ltd. (CHEK) Company Bio


Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening. The company was founded by Yoav Kimchy in April 2005 and is headquartered in Isfiya, Israel.


CHEK Latest News Stream


Event/Time News Detail
Loading, please wait...

CHEK Latest Social Stream


Loading social stream, please wait...

View Full CHEK Social Stream

Latest CHEK News From Around the Web

Below are the latest news stories about Check-Cap Ltd that investors may wish to consider to help them evaluate CHEK as an investment opportunity.

Is Check-Cap (NASDAQ:CHEK) In A Good Position To Invest In Growth?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Yahoo | January 2, 2021

Check-Cap Announces Exercise of Warrants For $9.6 Million Gross Proceeds

Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of the C-Scan®, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into cancer, today announced that it has entered into a definitive agreement with several existing institutional investors for the exercise of certain outstanding warrants to purchase up to an aggregate of 16,054,223 of its ordinary shares at a reduced exercise price of $0.60 per share. The warrants being exercised were issued by Check-Cap on several dates from November 2017 through May 2020 and have exercise prices ranging from $15.00 to $0.80 per share.

Yahoo | July 23, 2020

Read More 'CHEK' Stories Here

CHEK Price Returns

1-mo 5.84%
3-mo -19.70%
6-mo 381.11%
1-year 204.79%
3-year -60.34%
5-year -88.19%
YTD 254.35%
2020 -73.26%
2019 -20.00%
2018 -79.41%
2017 -62.98%
2016 24.34%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.7616 seconds.